4
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T35527 | PI3Kα-IN-4 | PI3Kα-IN-4 | |
PI3Kα-IN-4 is a potent, selective, and orally active PI3Kα inhibitor, demonstrating an IC50 of 1.8 nM and exhibiting antitumor activity[1]. | |||
T35488 | (S)-PI3Kα-IN-4 | (S)-PI3Kα-IN-4 | |
(S)-PI3Kα-IN-4 is a potent inhibitor of PI3Kα, with an IC50 of 2.3 nM. (S)-PI3Kα-IN-4 shows 38.3-, 4.25-, and 4.93-fold selectivity for PI3Kα over PI3Kβ, PI3Kδ, and PI3Kγ, respectively. (S)-PI3Kα-IN-4 can be used for the... | |||
T14214 | AMG 511 | PI3K | |
AMG 511 is a potent and orally available pan inhibitor of class I PI3Ks(Kis of 4 nM, 6 nM, 2 nM and 1 nM for PI3Kα, β, δ and γ, respectively). It exhibits anti-tumor activity in mouse glioblastoma xenograft model[1]. AMG... | |||
T3351 | Onatasertib | CC223,CC 223,CC-223 | Apoptosis , c-Fms , DNA-PK , FLT , PI3K , mTOR |
Onatasertib (CC223) is an orally available mTOR inhibitor with potential antitumor activity. Onatasertib inhibits the activity of mTOR, which may result in the induction of tumor cell apoptosis and a decrease in tumor ce... |